Kieran Mudryy

Partner, General Counsel

2017 - Current

We are a London-based firm focused on private equity and venture capital in life sciences. We work in high growth and high return segments of biotech - biologics, gene and cell therapy and RNA therapies.

Director

2014 - 2018

Investor and Board Representative

2017 - 2017

Director

2012 - 2017

Director

2011 - 2017

Partner and Head of Legal

2010 - 2017

Enso specialise in identifying early stage disruptive innovative technologies. We invest in products with the potential to become market leaders in high growth niche markets. The group has a strong European presence with portfolio companies located in Austria, Finland, Germany and the UK. Enso provides not only financial investment but also the leadership and industry expertise needed to accelerate commercial potential. Our team has developed high level expertise in cutting edge technological development making us uniquely positioned to understand the fine balance between the financial and application development needs of our portfolio partners.

In house legal counsel

2009 - 2010

The primary objective of the company is to build an international business network specialized in transforming scientific results into advanced technologies based on nano sized material and current developments in advanced materials science.

Trainee

2007 - 2009

Trainee

2008 - 2008

Paralegal

2006 - 2007